Aytu Biopharma (AYTU) Current Assets (2011 - 2026)
Aytu Biopharma (AYTU) posted Current Assets of $61.76 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 22.0% from $79.18 million a year earlier and down 8.3% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Current Assets (2011 - 2026) Analysis & Trends
Since fiscal Q4 2011, Aytu Biopharma has reported Current Assets for 57 quarters.
- Annual Current Assets shows a five-year compound annual growth rate of -10.1% (FY2021 to FY2026).
- In prior fiscal years, Aytu Biopharma's Current Assets was $79.18 million in FY2025 (+27.9%), $61.89 million in FY2024 (-15.0%), $72.83 million in FY2023 (+21.5%) and $59.93 million in FY2022 (-43.1%).
- The fiscal Q4 2026 figure stands as the lowest quarterly Current Assets since fiscal Q1 2025.
- On a year-over-year basis, Current Assets increased in four of the last eight quarters, with growth averaging 3.7%.
- The strongest year-over-year quarter for Current Assets in the past five years was fiscal Q1 2022, with growth of 36.0%; the weakest was fiscal Q4 2022, with a decline of 43.1%.
- According to Business Quant data, Current Assets for the three prior fiscal quarters was $67.33 million (Q3 2026), $76.24 million (Q2 2026) and $81.11 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | 61.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.76 Mn |
| Mar 31, 2026 | 67.33 Mn |
| Dec 31, 2025 | 76.24 Mn |
| Sep 30, 2025 | 81.11 Mn |
| Jun 30, 2025 | 79.18 Mn |
| Mar 31, 2025 | 72.51 Mn |
| Dec 31, 2024 | 63.05 Mn |
| Sep 30, 2024 | 60.74 Mn |
| Jun 30, 2024 | 61.89 Mn |
| Mar 31, 2024 | 71.13 Mn |
| Dec 31, 2023 | 71.37 Mn |
| Sep 30, 2023 | 70.60 Mn |
| Jun 30, 2023 | 72.83 Mn |
| Mar 31, 2023 | 78.47 Mn |
| Dec 31, 2022 | 70.61 Mn |
| Sep 30, 2022 | 74.42 Mn |
| Jun 30, 2022 | 59.93 Mn |
| Mar 31, 2022 | 77.95 Mn |
| Dec 31, 2021 | 87.54 Mn |
| Sep 30, 2021 | 89.04 Mn |
API Access
Aytu Biopharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();